Menu Search
Equities

Qlucore publ AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
5QO:FRA

Qlucore publ AB

Actions
  • Price (EUR)0.0355
  • Today's Change0.000 / -1.39%
  • Shares traded--
  • 1 Year change-81.70%
  • Beta0.7348
Data delayed at least 15 minutes, as of Feb 06 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Qlucore AB (publ) is a Sweden-based company primarily engaged in the software industry. The Company’s scope of activity revolves around developing Artificial-Intelligence-based (AI-based) software dedicated to the healthcare sector. The software’s aim is to establish a platform improving cancer care in terms of treatment strategies, and more, as well as other therapy areas. What is more, the Firm develops software which is committed to data analysis in relation to medical research. The Company’s software relies on AI-based machine learning and functions by transforming data sets into explanatory visualizations. Additionally, the Firm runs three software products: Qlucore Omics Explorer, Qlucore Diagnostics, as well as Qlucore Insights.

  • Revenue in SEK (TTM)9.28m
  • Net income in SEK-36.89m
  • Incorporated2007
  • Employees17.00
  • Location
    Qlucore publ ABIdeon Science Park, Scheelevagen 17LUND 223 70SwedenSWE
  • Phone+46 462863110
  • Websitehttps://www.qlucore.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.